Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

Cancer immunotherapy can effectively inhibit cancer progression by activating the
autoimmune system, with low toxicity and high effectiveness. Some of cancer …

The cuproptosis cell death pathway brings fresh opportunities for tumor therapy. However,
efficient and targeted cuproptosis induction in tumors is still a challenge. Unfortunately, the …

Cancer nanovaccines as one of immunotherapeutic approaches are able to attack tumors by
stimulating tumor-specific immunological responses. However, there still exist multiple …

Tumor vaccination is a promising approach for tumor immunotherapy because it presents
high specificity and few side effects. However, tumor vaccines that contain only a single …

Tumor immunotherapy is a safe and effective strategy for precision medicine. However,
immunotherapy for most cancer cases still ends in failure, with the root causes of the …

Biomimetic nanoparticles have recently emerged as a novel drug delivery platform to
improve drug biocompatibility and specificity at the desired disease site, especially the …

The postoperative recurrence and metastasis of triple negative breast cancer (TNBC) remain
one fatal reason for the failure of clinical treatments. Although the rise of immunotherapy has …

The current situation, heavily influenced by the ongoing pandemic, puts vaccines back into
the spotlight. However, the conventional and traditional vaccines present disadvantages …

There is growing interest in develo** cell membrane‐coated nanoparticles (CNPs) for
unique host cell mimicry and therapeutic applications. The continuous evolution of this …